We conclude that transient TGFβ-treatment transforms CDβGeo cells such that they are de-differentiated and persistently transdifferentiated with increased expression of EMT markers, changes in ECM components and increased sensitivity to tumour promotion. This evidence concerns the gene TGFB1 and neoplasm.